Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II results demonstrate efficacy of QMF-149 in patients with persistent asthma

Sep. 6, 2012

Mepolizumab reduces exacerbation rates in asthma patients

Sep. 6, 2012

Novel antithrombotic agents presented by Bristol-Myers Squibb

Sep. 6, 2012

GSK-961081 demonstrates efficacy as a bronchodilator in a phase II study

Sep. 5, 2012

Relmada Therapeutics devises extended-release delivery systems for REL-1041

Sep. 5, 2012

GlaxoSmithKline identifies novel DNA gyrase inhibitors for the treatment of tuberculosis

Sep. 5, 2012

A novel pan-JAK inhibitor shows promise for adjuvant-induced arthritis

Sep. 5, 2012

Novel HCV candidate identified by group in Taiwan

Sep. 5, 2012

Stem cell gene therapy improves erectile dysfunction in rats

Sep. 5, 2012

Genentech describes mTOR inhibitor chosen as development candidate

Sep. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...